Related Experiment Videos
Phototherapeutic keratectomy for map-dot-fingerprint corneal dystrophy
1St. Erik Eye Hospital, Stockholm, Sweden.
Cornea
|November 20, 1998
Summary
Excimer laser phototherapeutic keratectomy (PTK) effectively treats map-dot-fingerprint (MDF) dystrophy, improving vision and stabilizing corneal erosion symptoms. While generally safe and stable, some patients may experience hyperopic shifts.
Area of Science:
- Ophthalmology
- Corneal Surgery
- Laser Vision Correction
Background:
- Map-dot-fingerprint (MDF) dystrophy is a common anterior corneal dystrophy.
- Symptoms include reduced visual acuity, fluctuating vision, and recurrent corneal erosions.
- Surgical options are limited, necessitating evaluation of new treatment modalities.
Purpose of the Study:
- To evaluate the efficacy and safety of excimer laser phototherapeutic keratectomy (PTK) for treating MDF dystrophies.
- To assess visual acuity improvement and symptom resolution after PTK.
- To determine the long-term stability and potential adverse effects of PTK in MDF dystrophy.
Main Methods:
- A cohort of 30 eyes from 24 patients with MDF dystrophy underwent PTK.
- Treatment aimed to improve vision, heal recurrent erosions, or both.
- Follow-up averaged 30 months, with assessments of visual acuity, refraction, and corneal changes.
Main Results:
- Best spectacle-corrected visual acuity improved by two lines or more in 14 of 17 eyes with reduced vision.
- Fluctuating vision and monocular diplopia resolved in all treated eyes.
- No recurrence of dystrophy in the ablation zone was observed; 50% had asymptomatic changes outside the treatment zone.
Conclusions:
- Excimer laser PTK is an effective, safe, and stable treatment for MDF dystrophy.
- PTK successfully improves visual acuity and resolves associated symptoms.
- Hyperopic shift is a potential adverse effect in some cases.